1Tsiouris A, Walesby RK. Malignant pleural mesothelioma: current concepts in treatment [ J ]. Nat Clin Pract Oncol, 2007,4 ( 6 ) : 344 - 352.
2Hughes RS. Malignant pleural mesothelioma [ J ]. Am J Med Sci, 2005,329( 1 ) :29 -44.
3Barbanti-Brodano G, Sabbioni S, Martini F, et al. Simian virus 40 infection in humans and association with human diseases : results and hypotheses [ J ]. Virology,2004,318 ( 1 ) : 1 - 9.
6Sterman DH, Albelda SM. Advances in the diagnosis, evaluation and management of malignant pleural mesothelioma [ J ]. Respirology ,2005,10 ( 3 ) :266 - 283.
7Scherpereel A, Grigoriu B, Conti M, et al. Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma [J]. Am J Respir Crit Care Med,2006,173(10) :1155 - 1160.
8Grigoriu BD, Scherpereel A, Devos P, et al. Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment [ J ]. Clin Cancer Res, 2007,13 ( 10 ) : 2928 - 2935.
9Singhal S, Wiewrodt R, Malden LD, et al. Gene expression profiling of malignant mesothelioma [ J ]. Clin Cancer Res, 2003,9 ( 8 ) : 3080 - 3097.
10Gordon GJ ,Jensen RV, Hsiao LL, et al. Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma[ J]. Cancer Res, 2002,62:4963 - 4967.
2[3]Butchart EG,AshcroftT,Barnsley WC,et al.Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura.Thorax,1976,31:15
3[4]Curran D,Sahmoud T,Therasse P,et al.Prognostic factors in patients with pleural mesothelioma:The European Organisation for Research and Treatment of Cancer experience.J Clin Oncol,1998,16:145
4[5]Rusch VW,Venkatraman E.The importance of surgical staging in the treatment of malignant pleural mesothelioma.J Thorac Cardiovasc Surg,1996,111:815
5[7]The International Mesothelioma Interest Group.A proposed new international TNM staging system for malignant pleural mesothelioma.Chest,1995,108 (4):1122
7[9]Sugarbaker DJ,Flores RM,Jaklitsch MT,et al.Resection margins,extrapleural nodal status and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma:Results in 183 patients.J Thorac Cardiovasc Surg,1999,117:54
8[10]Sugarbaker DJ,Jaklitsch MT,Bueno R,et al.Prevention,early detection,and management of complications after 328 consecutive extrapleural pneumonectomies.J Thorac Cardiovasc Surg,2004,128:138
9[11]Shaw P,Agarwal R.Pleurodesis for malignant pleural effusions.Cochrane Database Syst Rev,2004.CD002916
10[12]Berghmans T,Paesmans M,Lalami Y,et al.Activity of chemotherapy and immunotherapy on malignant mesothelioma:A systematic review of the literature with meta-analysis.Lung Cancer,2002,38:111
